Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
VA New England Mental Illness, Research, Education and Clinical Center (MIRECC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.
J Dual Diagn. 2021 Apr-Jun;17(2):124-134. doi: 10.1080/15504263.2021.1904162. Epub 2021 May 13.
Opioid use disorder (OUD) is a significant problem among US veterans with increasing rates of OUD and overdose, and thus has substantial importance for service delivery within the Veterans Health Administration (VHA). Among individuals with OUD, several sex- specific differences have begun to emerge regarding co-occurring medical, psychiatric and pain-related diagnoses. The rates of such multimorbidities are likely to vary between men and women with OUD and may have important implications for treatment within the VHA but have not yet been studied. The present study utilized a data set that included all veterans receiving VHA health care during Fiscal Year (FY) 2012 (October 1, 2011 through September 30, 2012), who were diagnosed during the year with opioid dependence or abuse. VHA patients diagnosed with OUD nationwide in FY 2012 were compared by sex on proportions with OUD, and among those with OUD, on sociodemographic characteristics, medical, psychiatric and pain-related diagnoses, as well as on service use, and psychotropic and opioid agonist prescription fills. During FY 2012, 48,408 veterans were diagnosed with OUD, 5.77% of whom were women. Among those veterans with OUD, few sociodemographic differences were observed between sexes. Female veterans had a higher rate of psychiatric diagnoses, notably mood, anxiety and personality disorders, as well as higher rates of pain-related diagnoses, such as headaches and fibromyalgia, while male veterans were more likely to have concurrent, severe medical co-morbidities, including hepatic disease, HIV, cancers, peripheral vascular disease, diabetes and related complications, and renal disease. There were few differences in health service utilization, with women reporting greater receipt of prescriptions for anxiolytic/sedative/hypnotics, stimulants and lithium. Men and women did not differ in receipt of opioid agonist medications or mental health/substance use treatments. There are substantial sex-specific differences in patterns of multimorbidity among veterans with OUD, spanning medical, psychiatric and pain-related diagnoses. These results illustrate the need to view OUD as a multimorbid condition and design interventions to target such multimorbidities. The present study highlights the potential benefits of sex-specific treatment and prevention efforts among female veterans with OUD and related co-occurring disorders.
阿片类药物使用障碍(OUD)是美国退伍军人中一个严重的问题,OUD 及药物过量的发生率不断上升,因此对退伍军人健康管理局(VHA)的服务提供具有重要意义。在 OUD 患者中,一些与共病相关的医学、精神科和疼痛相关诊断开始出现性别特异性差异。这些共病的发生率可能在男性和女性 OUD 患者之间有所不同,并且可能对 VHA 内的治疗具有重要意义,但尚未进行研究。本研究利用了一个数据集,该数据集包括在 2012 财年(2011 年 10 月 1 日至 2012 年 9 月 30 日)期间接受 VHA 医疗保健的所有退伍军人,他们在当年被诊断为阿片类药物依赖或滥用。2012 财年,全国范围内被诊断为 OUD 的 VHA 患者按性别比较 OUD 的比例,以及在患有 OUD 的患者中,比较社会人口统计学特征、医学、精神科和疼痛相关诊断以及服务使用情况,以及精神药物和阿片类激动剂处方的使用情况。2012 财年,有 48408 名退伍军人被诊断为 OUD,其中 5.77%为女性。在患有 OUD 的退伍军人中,性别之间几乎没有观察到社会人口统计学差异。女性退伍军人的精神科诊断率较高,特别是情绪、焦虑和人格障碍,以及头痛和纤维肌痛等疼痛相关诊断的发生率较高,而男性退伍军人更有可能同时患有严重的医学合并症,包括肝脏疾病、艾滋病毒、癌症、外周血管疾病、糖尿病及其相关并发症和肾脏疾病。卫生服务利用方面几乎没有差异,女性报告接受更多的抗焦虑/镇静/催眠药、兴奋剂和锂的处方。男性和女性在接受阿片类激动药物或心理健康/物质使用治疗方面没有差异。患有 OUD 的退伍军人中,存在多种疾病的模式存在显著的性别特异性差异,涵盖医学、精神科和疼痛相关的诊断。这些结果表明,需要将 OUD 视为一种多种疾病并存的疾病,并设计干预措施来针对这些多种疾病。本研究强调了针对女性退伍军人 OUD 及相关共病进行性别特异性治疗和预防的潜在益处。